Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

In a recent filing with the Securities and Exchange Commission, Mangoceuticals, Inc., a Texas-based health services company, ...

In a live taping of "The Readout LOUD" at #JPM25, Eli Lilly CEO Dave Ricks talks Trump, Medicare's drug price negotiation, ...

Eli Lilly CEO said he believed the company could find “significant common cause” with the Trump administration, even if there ...

Eli Lilly forecasts $45 billion revenue for 2024, 32% higher than last year. Medicare changes and stocking issues impact the revised guidance.

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

Tesla stock has had an incredible run, but is well off its all time high reached on Dec. 17. Investors might need some more ...

A liquidator called Gordon Brothers has already made an offer, but the Ohio-based company can try to attract a higher bid, ...